Featured Research

from universities, journals, and other organizations

NIAID Funds Pediatric AIDS Clinical Trials Group

February 25, 1997
National Institute of Allergy and Infectious Diseases
The National Institute of Allergy and Infectious Diseases has awarded 23 four-year grants to continue the work of the Pediatric AIDS Clinical Trials Group.

The National Institute of Allergy and Infectious Diseases (NIAID) has awarded 23 four-year grants to continue the work of the Pediatric AIDS Clinical Trials Group (ACTG). A nationwide clinical trials network, the group evaluates improved strategies to prevent infants of infected mothers from acquiring HIV in utero or during birth, and for treating children and adolescents already infected with the virus. First-year funding for the new awards totals $32 million.

The money will support 21 AIDS Clinical Trials Units (ACTUs, listed below), a Statistical and Data Management Center, and a new Pediatric ACTG Coordinating and Operations Center. The latter will provide scientific and managerial leadership and perform centralized, advanced laboratory studies.

Through June 1996, 9,870 cases of AIDS in children and adolescents as old as 19 years had been reported to the U.S. Centers for Disease Control and Prevention (CDC). Of the 7,296 cases in children under age 13, nine out of 10 patients acquired HIV perinatally from their infected mothers. These data reinforce the need to develop better strategies to prevent and treat mother-to-infant HIV transmission.

"The Pediatric ACTG brings together a superbly qualified group of investigators focused on the special problems of preventing and treating AIDS and associated opportunistic infections in infants, children and adolescents," comments NIAID Director Anthony S. Fauci, M.D. "We are confident that the Pediatric ACTG will continue to make significant contributions to improving the lives of all young people infected with HIV."

Stephen A. Spector, M.D., principal investigator of the University of California at San Diego ACTU, will be Group Leader of the Pediatric ACTG. As such, he will direct its Coordinating and Operations Center, which will be managed by Social and Scientific Systems in Bethesda, Md.

"The restructured Pediatric ACTG will greatly enhance our ability to conduct trials that address questions of high public health and scientific priority," says Dr. Spector. One group priority is to incorporate pathogenesis-based research into clinical trials. These studies will enable the ACTU investigators to better define the course of disease in children and to analyze how HIV infection and its treatments affect the developing immune system. The Pediatric ACTG is uniquely suited to carry out such studies because they require integrating clinical and laboratory research.

The Statistical and Data Management Center will be headed by Richard Gelber, Ph.D., of the Harvard School of Public Health.

The 21 clinical trials sites include 20 of the 22 current NIAID- sponsored Pediatric ACTUs and one new site in Alabama. The funding level for the Pediatric ACTG is consistent with the recommendations of the Report of the NIH AIDS Research Program Evaluation Working Group, chaired by Princeton virologist Arnold Levine, Ph.D. This report--an external review of the NIH AIDS program issued by the NIH Office of AIDS Research in 1996--recommended a decreased level of funding for the Pediatric ACTG given the changing epidemiology of HIV infection in children in the United States.

In addition to the NIAID-sponsored components of the Pediatric ACTG, the National Institute of Child Health and Human Development (NICHD) currently funds 33 smaller clinical trials sites. The NICHD investigators participate in group committees and protocol development teams, enroll patients and share the same scientific group leadership as NIAID. Together, these 54 clinical sites provide the structure and resources for addressing the Pediatric ACTG's goals.

Moreover, through the Ryan White Service Program, the U.S. Public Health Service enhances pediatric AIDS clinical research by providing resources such as day care and travel money to facilitate the participation of HIV-infected women and children in NIH-sponsored clinical research. Health care providers receiving funds from this program are located near 20 of the 21 NIAID clinical sites and can easily make patient referrals to the group's trials.

As of February 1997, the Pediatric ACTG had initiated 60 trials, and 27 studies are now recruiting patients. Cumulative enrollment since 1987 totals 10,867 children, adolescents and pregnant women. Among its most significant contributions, the group has: 1) demonstrated that antiretroviral therapy given to HIV-infected pregnant women and their newborns can reduce the risk of perinatal transmission by two thirds; 2) showed that IVIG can effectively prevent serious bacterial infections in children with HIV; 3) demonstrated that ddI or ddI plus AZT are superior to AZT monotherapy for children with symptomatic HIV infection or AIDS; and 4) developed guidelines for preventing Pneumocystis carinii pneumonia in HIV-infected children.

The original NIAID ACTG established in 1987 included two sites that enrolled children with AIDS. Additional pediatric sites were added in 1988 and 1989, and again in 1992. Following recommendations of an independent advisory panel, the Adult and Pediatric ACTGs will now operate separately. Currently there are 30 adult clinical sites.

For information on Pediatric ACTG trials currently open to enrollment, call the AIDS Clinical Trials Information Service at 1-800-TRIALS-A (1-800-874-2572), Monday through Friday, 9:00 a.m. to 7:00 p.m. Eastern time. Bilingual health specialists are available to talk to Spanish-speaking callers.

NIAID and NICHD are components of the National Institutes of Health (NIH). NIAID conducts and supports research aimed at preventing, diagnosing and treating illnesses such as AIDS and other sexually transmitted diseases, tuberculosis, asthma and allergies. NIH is an agency of the U.S. Department of Health and Human Services. ### Press releases, fact sheets and other materials from NIAID are available on the Internet via the NIAID home page at http://www.niaid.nih.gov.


ALABAMA University of Alabama at Birmingham Robert Pass, M.D.

CALIFORNIA University of California at Los Angeles Yvonne J. Bryson, M.D.

University of California at San Diego Stephen A. Spector, M.D.

University of California at San Francisco Diane W. Wara, M.D.

DISTRICT OF COLUMBIA Children's National Medical Center John L. Sever, M.D., Ph.D.

FLORIDA University of Miami School of Medicine Gwendolyn B. Scott, M.D.

ILLINOIS Children's Memorial Hospital Ram Yogev, M.D.

LOUISIANA Tulane University School of Medicine Russell Van Dyke, M.D.

MARYLAND Johns Hopkins University Andrea Ruff, M.D.

MASSACHUSETTS Children's Hospital Kenneth McIntosh, M.D.

University of Massachusetts Medical Center John L. Sullivan, M.D.

NEW JERSEY UMDNJ-New Jersey Medical School James Oleske, M.D., M.P.H.

NEW YORK Bronx-Lebanon Hospital Center Andrew A. Wiznia, M.D.

Columbia University Anne A. Gershon, M.D.

New York University Medical Center William Borkowsky, M.D.

NORTH CAROLINA Duke University Medical Center Ross McKinney, Jr., M.D.

PENNSYLVANIA Children's Hospital of Philadelphia Stuart E. Starr, M.D.

PUERTO RICO University of Puerto Rico Clemente Diaz, M.D.

TENNESSEE St. Jude Children's Research Hospital Walter Hughes, M.D.

TEXAS Baylor College of Medicine William T. Shearer, M.D., Ph.D. WASHINGTON Children's Hospital and Medical Center Lisa M. Frenkel, M.D.

Story Source:

The above story is based on materials provided by National Institute of Allergy and Infectious Diseases. Note: Materials may be edited for content and length.

Cite This Page:

National Institute of Allergy and Infectious Diseases. "NIAID Funds Pediatric AIDS Clinical Trials Group." ScienceDaily. ScienceDaily, 25 February 1997. <www.sciencedaily.com/releases/1997/02/970225134127.htm>.
National Institute of Allergy and Infectious Diseases. (1997, February 25). NIAID Funds Pediatric AIDS Clinical Trials Group. ScienceDaily. Retrieved April 23, 2014 from www.sciencedaily.com/releases/1997/02/970225134127.htm
National Institute of Allergy and Infectious Diseases. "NIAID Funds Pediatric AIDS Clinical Trials Group." ScienceDaily. www.sciencedaily.com/releases/1997/02/970225134127.htm (accessed April 23, 2014).

Share This

More Health & Medicine News

Wednesday, April 23, 2014

Featured Research

from universities, journals, and other organizations

Featured Videos

from AP, Reuters, AFP, and other news services

Big Pharma Braces for M&A Wave

Big Pharma Braces for M&A Wave

Reuters - Business Video Online (Apr. 22, 2014) Big pharma on the move as Novartis boss, Joe Jimenez, tells Reuters about plans to transform his company via an asset exchange with GSK, and Astra Zeneca shares surge on speculation that Pfizer is looking for a takeover. Joanna Partridge reports. Video provided by Reuters
Powered by NewsLook.com
How Smaller Plates And Cutlery Could Make You Feel Fuller

How Smaller Plates And Cutlery Could Make You Feel Fuller

Newsy (Apr. 22, 2014) NBC's "Today" conducted an experiment to see if changing the size of plates and utensils affects the amount individuals eat. Video provided by Newsy
Powered by NewsLook.com
How to Master Motherhood With the Best Work/Life Balance

How to Master Motherhood With the Best Work/Life Balance

TheStreet (Apr. 22, 2014) In the U.S., there are more than 11 million couples trying to conceive at any given time. From helping celebrity moms like Bethanny Frankel to ordinary soon-to-be-moms, TV personality and parenting expert, Rosie Pope, gives you the inside scoop on mastering motherhood. London-born entrepreneur Pope is the creative force behind Rosie Pope Maternity and MomPrep. She explains why being an entrepreneur offers the best life balance for her and tips for all types of moms. Video provided by TheStreet
Powered by NewsLook.com
Catching More Than Fish: Ugandan Town Crippled by AIDS

Catching More Than Fish: Ugandan Town Crippled by AIDS

AFP (Apr. 22, 2014) The village of Kasensero on the shores of Lake Victoria was where HIV-AIDS was first discovered in Uganda. Its transient population of fishermen and sex workers means the nationwide programme to combat the virus has had little impact. Duration: 02:30 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.


Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News


Free Subscriptions

Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile

Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins